https://www.marketscreener.com/quote/stock/EPIRUS-BIOPHARMACEUTICALS-54548046/news/EPIRUS-Biopharmaceuticals-Inc-Initiates-Pivotal-Global-Phase-3-Clinical-Study-for-BOW015-Inflixim-38104872/?utm_source=telegram&utm_medium=social&utm_campaign=share